Tarsier Pharma LTD F-1 registration statements
The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.
Tarsier Pharma Ltd. has filed an amended registration statement for its initial public offering, aiming to raise capital for the development of novel therapies for blinding eye diseases.